- Home
- ABEO vs PINE Comparison
ABEO vs PINE Comparison
Compare ABEO & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- PINE
- Stock Information
- Founded
- ABEO 1974
- PINE 2019
- Country
- ABEO United States
- PINE United States
- Employees
- ABEO N/A
- PINE N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- PINE Real Estate Investment Trusts
- Sector
- ABEO Health Care
- PINE Real Estate
- Exchange
- ABEO Nasdaq
- PINE Nasdaq
- Market Cap
- ABEO 281.0M
- PINE 205.4M
- IPO Year
- ABEO 1980
- PINE 2019
- Fundamental
- Price
- ABEO $4.60
- PINE $14.71
- Analyst Decision
- ABEO Strong Buy
- PINE Strong Buy
- Analyst Count
- ABEO 5
- PINE 3
- Target Price
- ABEO $18.20
- PINE $17.17
- AVG Volume (30 Days)
- ABEO 1.4M
- PINE 107.4K
- Earning Date
- ABEO 11-13-2025
- PINE 10-23-2025
- Dividend Yield
- ABEO N/A
- PINE 7.80%
- EPS Growth
- ABEO N/A
- PINE N/A
- EPS
- ABEO 0.99
- PINE N/A
- Revenue
- ABEO $400,000.00
- PINE $57,423,000.00
- Revenue This Year
- ABEO N/A
- PINE $14.37
- Revenue Next Year
- ABEO $324.71
- PINE $0.71
- P/E Ratio
- ABEO $4.83
- PINE N/A
- Revenue Growth
- ABEO N/A
- PINE 14.81
- 52 Week Low
- ABEO $3.93
- PINE $13.10
- 52 Week High
- ABEO $7.54
- PINE $18.57
- Technical
- Relative Strength Index (RSI)
- ABEO 28.13
- PINE 64.65
- Support Level
- ABEO $5.29
- PINE $13.63
- Resistance Level
- ABEO $5.41
- PINE $14.90
- Average True Range (ATR)
- ABEO 0.24
- PINE 0.32
- MACD
- ABEO -0.06
- PINE 0.13
- Stochastic Oscillator
- ABEO 1.34
- PINE 83.86
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.